Michael Feld
Psychiatry · Northbrook, ILNPI 1427057322
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $871,383 of the $1,059,706 with a category attached, or 82.2%. 16 manufacturers reported payments, led by Tris Pharma Inc at 30.8% of the total. Reporting peaked in 2023 at $337,110 and has fallen 60.1% since, to $134,374 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,902 payments — averaging $557.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$327K
- Corium, LLC$214K
- Supernus Pharmaceuticals, Inc.$201K
- Ironshore Pharmaceuticals Inc.$174K
- Neos Therapeutics, LP$127K
- Aytu Biopharma, Inc.$15K
- plus $1K from 10 others
What the payments were for
- Consulting fees$13,2701%
- Speaking & faculty fees$871,38382%
- Travel & lodging$145,70114%
- Food & beverage$29,3333%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 578 | $326,583 |
| Corium, LLC | 316 | $214,267 |
| Supernus Pharmaceuticals, Inc. | 349 | $200,711 |
| Ironshore Pharmaceuticals Inc. | 294 | $174,285 |
| Neos Therapeutics, LP | 269 | $127,347 |
| Aytu Biopharma, Inc. | 22 | $15,394 |
| Lundbeck LLC | 38 | $556 |
| Otsuka America Pharmaceutical, Inc. | 18 | $324 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $60 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Noven Therapeutics, LLC | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Rhodes Pharmaceuticals L.p. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$320,328
- Quillichew ER$267,296
- Quillivant$246,235
- Azstarys$209,210
- QELBREE$189,766
- Adzenys XR-ODT$117,473
- Cotempla XR-ODT$109,024
- JORNAY PM$92,174
- Jornay PM 20mg capsules (Bottle of 100)$77,707
- Quillivant XR$21,300
- ZolpiMist$5,696
- Karbinal$112
How this compares
$1,059,706 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 20 | $30,762 |
| Clomipramine Hcl | 73 | $27,350 |
| Aripiprazole | 127 | $25,289 |
| Chlorpromazine Hcl | 13 | $22,181 |
| Quetiapine Fumarate | 312 | $15,471 |
| Paliperidone ErPaliperidone | 24 | $11,255 |
| TrintellixVortioxetine Hydrobromide | 21 | $9,629 |
| Guanfacine Hcl | 131 | $7,767 |
| Modafinil | 12 | $6,209 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $5,277 |
| Clozapine | 66 | $5,087 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $4,958 |
| Sertraline Hcl | 419 | $4,849 |
| Risperidone | 331 | $4,599 |
| Ziprasidone Hcl | 12 | $4,481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $324 | $30,76220 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $60 | $14,58634 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Northbrook
- Barry GershunyNorthbrook$96K
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.